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OBJECTIVE: A number of researchers have suggested the use of sodium hyaluronate carboxymethyl cel-
lulose (HA-CMC) membrane for preventing postoperative adhesion. This study evaluated the anti-adhesive
effect and safety of a newly developed HA-CMC solution in thyroidectomy.
METHODS: Seventy-four patients who underwent thyroidectomy were prospectively randomized. 
In the study group of 38 patients, 5 mL HA-CMC solution was applied to the operative field after thy-
roidectomy. The subjects were asked about adhesive symptoms using a four-item questionnaire at 
2 weeks, 2 months and 6 months after surgery. In addition, three items on the appearance of neck wrin-
kles and scars were evaluated by a physician. Each item was scored from 0 to 10.
RESULTS: The mean (± standard deviation) total adhesion score at each visit was 15.22 ± 8.99, 10.42 ± 8.41,
and 7.24 ± 5.83 for the control group and 19.29 ± 9.71, 9.46 ± 5.71, and 6.03 ± 4.32 for the study group.
Total adhesion scores for both groups decreased with time (p < 0.001), but no significant differences were
noted between the two groups (p > 0.066). There were no complications related to the HA-CMC solution.
CONCLUSION: The HA-CMC solution did not decrease subjective or objective postoperative adhesion
in patients undergoing thyroid surgery, although it was biologically safe. [Asian J Surg 2010;33(1):25–30]
Key Words: anti-adhesive agents, postoperative adhesion, sodium hyaluronate carboxymethyl cellulose,
thyroidectomy
Introduction
The majority of thyroid malignancies are either papillary
thyroid cancer (PTC) or follicular thyroid cancer (FTC).
These two types account for approximately 80% and 10% of
diagnosed thyroid malignancies in the United States, respec-
tively.1–3 Both types of thyroid cancer have an excellent
prognosis. PTC has a 20-year survival rate of ≥ 90%, and
FTC has a 10-year survival rate of 80% for encapsulated
malignancies confined to the thyroid gland.4,5 These ex-
cellent prognoses accentuate the lower complication rate
of thyroid surgery and the improved postoperative quality
of life. Many studies have evaluated major complications of
thyroidectomy, such as hypoparathyroidism and recur-
rent laryngeal nerve injury, but postoperative adhesive
symptoms have been overlooked in those previous studies.
Many patients complain of adhesive symptoms including
swallowing difficulty or a pulling sensation during neck
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extension. Moreover, internal adhesion scars after neck
surgery are often externally visible (Figure 1).
Numerous anti-adhesive agents such as nadroparine
calcium and aprotinin have been introduced. Barrier agents
such as a sodium hyaluronate and carboxymethyl cellu-
lose (HA-CMC) membrane (Seprafilm; Genzyme Corp.,
Cambridge, MA, USA) and an oxidized regenerated cellu-
lose barrier (Interceed; Ethicon Inc., Somerville, NJ, USA)
have also been used. The efficacy of these agents has been
evaluated exclusively in the peritoneal and pelvic cavities.
Studies of these agents have primarily focused on evalu-
ating abdominal or pelvic pain, as well as intestinal ob-
structions and infertility.6–9 No studies have examined
postoperative adhesion after neck surgery.
A HA-CMC solution (Guardix; Hanmi Medicare, Seoul,
South Korea) was developed to reduce the formation of
postoperative adhesions. Each chemical constituent in
the solution has been shown to prevent the development
of adhesion.10–12 The HA-CMC solution is composed of
the same components used in an HA-CMC membrane;
however, it is easier to apply to a small operative field
because it is liquid. As far as we know, this is the first ran-
domized prospective study to evaluate the anti-adhesive
effect and safety of HA-CMC solution in thyroidectomy.
Patients and methods
Patients
Between April and September 2007, 86 patients who
underwent thyroid surgery were initially enrolled in this
study. Patients were excluded if they had a history of 
previous cervical surgery, an uncontrolled medical illness, 
or drug abuse. Following approval by the Institutional
Review Board of Seoul National University Hospital,
Seoul, Korea, all patients gave written informed consent
to participate in the study. Patients were randomized into
the study group of 44 patients and the control group 
of 42 patients using a web-based randomized allocation
protocol. This system used a 4 × 6 random permuted
block operated by the Medical Research Collaborating
Center, Seoul, Korea. Randomization was done after the
completion of haemostasis and before closing the strap
muscle.
Anti-adhesion
Each patient in the initial study group had 5 mL HA-CMC
solution (Guardix; Hanmi Medicare) applied to the opera-
tive field: the thyroid bed, around the trachea, the flapped
area beneath the platysma, and the dissected area if modi-
fied radical neck dissection (MRND) was included. Patients
in the initial control group did not have the HA-CMC
solution applied. Patients were excluded from the study if
they needed a second operation because of surgical com-
plications, or if they required completion thyroidectomy
as indicated by the final pathological results. All patients
and the examiner were blinded to the group allocation. At
2 weeks, 2 months and 6 months postoperatively, adhe-
sion severity was assessed using seven items. Four out of
the seven assessed subjective discomfort related to post-
operative adhesion, and responses were graded on a visual
analogue scale from 0 (no discomfort or natural wrinkles)
to 10 (severe discomfort and unnatural wrinkles; Table 1).
The remaining three items assessed objective findings
related to postoperative adhesion, each of which was
graded by one physician (Won Seo Park) from 0 (natural
wrinkles and no evidence of inflammatory reaction) to 10
(unnatural wrinkles and noticeable scarring).
Statistical analysis
Statistical analysis was performed using SPSS version
14.0 (SPSS Inc., Chicago, IL, USA). An independent t test
or Mann-Whitney U test was used to compare the total
adhesion score between the study and control groups at
each postoperative time point. Analysis of variance was
used to compare the total adhesion score at different time
points in the study and control groups. Continuous vari-
ables were expressed as the mean ± standard deviation,
and statistical significance was defined as p < 0.05.
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Figure 1. Post-thyroidectomy adhesion. A noticeable scar and
marked sunken wrinkles above the scar are evident (pictured at
postoperative month 6).
Results
Of the 86 initially enrolled patients, six each from the con-
trol and study groups were excluded during the course of
the study. Nine of these 12 excluded patients failed to
appear in a timely manner. Two of the 12 excluded patients
underwent a second neck operation and both had been
accidentally enrolled into the study group: one underwent
lymphatic ligation on postoperative day 5, and the other
underwent level II lymph node dissection at 6 months
after primary total thyroidectomy with bilateral MRND.
Both operative fields were minimally adhesive, such that
we could easily dissect the subplatysmal area and clearly
identify the anatomical structures. The final excluded
patient received radiotherapy for incipient anaplastic
changes found at final pathological assessment.
The clinical characteristics of the 74 patients finally
included are shown in Table 2. The two groups were com-
parable with regard to sex, age, postoperative diagnosis,
surgical method, and operation time. Postoperative com-
plications such as recurrent laryngeal nerve paralysis,
hypoparathyroidism, bleeding and infection are described
in Table 3. There were no significant differences in com-
plication rate between the two groups.
The total adhesion scores for both groups signifi-
cantly decreased with time (p < 0.001; Figure 2). We also
compared the data between the two groups at each time
point, and no significant differences were found at any
time (p > 0.06; Table 4). Moreover, there were no signifi-
cant differences in the score of each assessment item at
any time point (p > 0.09; Table 5).
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Table 1. Items used to assess postoperative adhesion after 
thyroidectomy*
Assessment items
Subjective discomforts 1. How much difficulty do you 
of the patient have in swallowing saliva?
2. How much difficulty do you
have in swallowing water?
3. How much difficulty do you
have swallowing in solid
foods?
4. Do you think your neck
wrinkles are unnatural? 
Objective findings by 5. Symmetry and naturalness of 
the physician neck wrinkles when the patient
rests
6. Symmetry and naturalness of
neck wrinkles when the
patient extends his/her neck
7. Degree of inflammatory
reaction and scar formation in
the surgical field
*Each item was scored from 0 to 10 with increasing severity.
Table 2. Clinical characteristics of patients in the control and study groups
Characteristic Control group (n= 36) Study group (n= 38) p
Sex 0.234
Male 12 (33.3%) 8 (21.1%)
Female 24 (66.7%) 30 (78.9%)
Age (yr)* 51.1 ± 10.0 (28–68) 50.8 ± 11.7 (26–74) 0.907
Postoperative diagnosis 0.863
Benign 7 (19.4%) 8 (21.1%)
Malignant 29 (80.6%) 30 (78.9%)
Operative method 0.905
Ipsilateral lobectomy 3 (8.3%) 7 (18.4%)
Subtotal lobectomy 6 (16.7%) 2 (5.3%)
Total thyroidectomy 14 (38.9%) 12 (31.6%)
Total thyroidectomy and MRND 12 (33.3%) 17 (44.7%)
Ipsilateral lobectomy and MRND 1 (2.8%) 0 (0%)
Duration of operation (min)* 97 ± 21.6 (63–165) 93.2 ± 21.8 (50–140) 0.452
*Values are expressed as mean ± standard deviation (range). MRND = modified radical neck dissection.
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Table 3. Comparison of complications between the control and study groups
Complications Control group (n= 36) Study group (n= 38) p
Transient RLN palsy 4 (11.1%) 5 (13.2%) 0.788
Permanent RLN palsy 0 0
Transient hypoparathyroidism 7 (19.4%) 7 (18.4%) 0.911
Permanent hypoparathyroidism 1 (2.8%) 0 0.301
Bleeding 0 0
Infection 0 0


























Figure 2. Mean total adhesion scores at each postoperative time
point. The scores significantly decreased with time in both
groups (p< 0.001).
When MRND was performed during surgery, the skin
incision was extended toward the affected side and a
broader surgical flap was formed. We expected that adhe-
sive symptoms and/or signs would be more severe in
patients who underwent MRND in addition to thyroidec-
tomy. Forty-four patients (20 from the control group and
24 from the study group) underwent MRND in addition to
thyroidectomy, while 30 patients (10 from the control group
and 20 from the study group) had thyroidectomy without
MRND. Although there were no significant differences in
the total adhesion score at postoperative week 2 and month
2 between the patients with MRND and those without
(p = 0.413 and 0.422, respectively), the total adhesion score
at postoperative month 6 was significantly higher for those
who underwent MRND (p = 0.005). However, the HA-
CMC solution failed to show any significant anti-adhesive
effects in the study group compared with the control
group, irrespective of MRND (p = 0.722; Table 6).
Discussion
The aim of this study was to evaluate the anti-adhesive
effect and safety of HA-CMC solution in thyroidectomy.
We showed that there was no significant difference in the
total adhesion score between patients in whom the HA-
CMC solution was applied during surgery and the control
group. The first possible reason why we failed to show any
anti-adhesive effect was a deficiency in the questionnaire
items, which was inadequate in describing the various
adhesive symptoms. In addition, the questionnaire might
not have been directly proportional to histological adhe-
sion, which was not measured. The second possible expla-
nation is that the solution failed to remain for a sufficient
time period to prevent adhesion due to drain insertion.
This is believed to be the first prospective randomized
controlled study to evaluate the effects of an adhesion
barrier in neck surgery. It is also the first study to track the
changes in postoperative adhesion after thyroidectomy
over a 6-month period. An ideal adhesion barrier should
be degradable, and should not cause a foreign body reac-
tion, impair wound healing, or promote infection.13,14 To
prevent contact between injured areas, a barrier agent
should remain effective for an adequate time to allow re-
establishment of the mesothelium.15 Although several stud-
ies have suggested that the insertion of a drain makes no
significant difference to seroma or haematoma forma-
tion,16,17 we have traditionally used a closed suction drain
at the thyroid bed for 2 days after thyroidectomy, and we
followed this standard procedure in the present study. 
We speculated that the HA-CMC solution might have run
out via the drain before an adequate time was reached to
achieve a reduction in postoperative adhesion, although
its amount was very minimal. These findings suggest that
we should increase the viscosity of the HA-CMC solution
and undertake a further study to compare our results
with a control group without a drain.
There were no complications related to the application
of the HA-CMC solution in the study group. Seprafilm,
which has the same components as our solution, has been
shown to be safe for use in abdominal or pelvic surgery,
with respect to abscess formation, pulmonary embolism,
and foreign body reactions; neither did seprafilm have
adverse effects on the oncological outcome of adjuvant
therapy.18,19 However, wrapping the suture or staple line
of a fresh bowel anastomosis should be avoided due to the
increased risk of sequelae associated with anastomotic
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Table 5. Comparison of adhesion score of each assessed item between the control and study groups at each postoperative time point*
Postoperative time Item no. Control group Study group p
Week 2 1 2.36 ± 2.03 (0–8) 2.97 ± 2.49 (0–8) 0.324
2 2.06 ± 2.38 (0–10) 2.95 ± 2.95 (0–10) 0.225
3 1.44 ± 1.51 (0–4.5) 2.34 ± 2.25 (0–8) 0.096
4 2.58 ± 2.38 (0–10) 3.39 ± 2.49 (0–10) 0.129
5 2.56 ± 1.92 (0–8) 2.47 ± 1.47 (0–6) 0.886
6 2.69 ± 1.86 (0–8) 2.92 ± 1.50 (0–8) 0.313
7 1.53 ± 1.08 (0–4) 2.24 ± 1.88 (0–8) 0.154
Month 2 1 1.75 ± 2.17 (0–8) 1.42 ± 1.50 (0–6) 0.830
2 0.96 ± 1.82 (0–6) 0.86 ± 1.63 (0–6.5) 0.762
3 0.42 ± 1.44 (0–8) 0.50 ± 0.99 (0–4) 0.209
4 2.85 ± 2.88 (0–10) 2.39 ± 2.22 (0–9) 0.708
5 2.31 ± 1.75 (0–8) 2.24 ± 1.15 (0–5) 0.681
6 1.97 ± 1.84 (0–9) 1.84 ± 1.33 (0–7) 0.825
7 0.17 ± 0.56 (0–3) 0.21 ± 0.41 (0–1) 0.279
Month 6 1 1.04 ± 1.49 (0–5) 0.74 ± 1.03 (0–4) 0.605
2 0.50 ± 1.03 (0–4) 0.34 ± 0.85 (0–4) 0.595
3 0.28 ± 0.88 (0–4) 0.21 ± 0.74 (0–4) 0.904
4 1.81 ± 1.58 (0–7) 1.76 ± 1.51 (0–6) 0.849
5 2.14 ± 1.50 (0–8) 1.87 ± 1.28 (0–5) 0.424
6 1.39 ± 1.54 (0–7) 1.08 ± 1.00 (0–4) 0.630
7 0.08 ± 0.50 (0–3) 0.03 ± 0.16 (0–1) 0.954
*Scores are expressed as mean ± standard deviation (range).
Table 4. Comparison of total adhesion score between the control and study groups at each postoperative time point*
Postoperative time Control group Study group p
Week 2 15.22 ± 8.99 (3–33) 19.29 ± 9.71 (4–38) 0.066
Month 2 10.42 ± 8.41 (1–34) 9.46 ± 5.71 (2–29) 0.567
Month 6 7.24 ± 5.83 (1–23) 6.03 ± 4.32 (1–20) 0.312
Sum 32.87 ± 19.68 (6–85) 34.77 ± 15.53 (8–65) 0.644
*Scores are expressed as mean ± standard deviation (range).
Table 6. Comparison of total adhesion score between the con-






Week 2 No 14.7 ± 9.8 18.0 ± 9.9
Yes 16.1 ± 7.6 20.9 ± 9.5
Month 2 No 10.5 ± 9.0 8.2 ± 3.9
Yes 10.3 ± 7.7 11.1 ± 7.1
Month 6 No 6.2 ± 4.5 6.0 ± 3.3
Yes 9.0 ± 7.5 6.1 ± 5.4
*Data presented according to modified radical neck dissection (p =
0.722, by repeated measures analysis of variance). MRND = modified
radical neck dissection.
leakages.18 Considering our results and the absence of such
anastomosis in the operative field, it appears that the HA-
CMC solution is safe to apply during thyroidectomy.
Most patients in the present study showed signs and
symptoms of postoperative adhesion to some degree. At
present, there is no reliable method for measuring the
adhesion grade, and we could not do other than using the
questionnaire with a visual analogue scale. Thirty-seven
patients (50%) showed a total adhesion score of >15 at post-
operative week 2, although the score diminished with time.
Nine patients (12%) reported a total adhesion score of > 15
at postoperative month 2, which could be considered as too
large to regard as a trivial complication. Primarily as a result
of the loss of normal tissue planes caused by postoperative
adhesion, a second thyroid operation is associated with a
high rate of complications, such as hypoparathyroidism
and recurrent laryngeal nerve injury.20,21 Additional study is
needed to investigate the possible benefit of the prior appli-
cation of HA-CMC solution in neck reoperation. Our
results suggest that further research should be carried out
on adhesion barriers for decreasing postoperative adhesion.
In conclusion, the present study indicates that signs and
symptoms of postoperative adhesion after thyroidectomy
are common but decrease over time. The application of an
HA-CMC solution in thyroidectomy is safe but has ques-
tionable efficacy. Further investigation of the HA-CMC
solution in thyroid surgery without a drain is required.
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